GB2110086A - Subcutaneous implant - Google Patents
Subcutaneous implant Download PDFInfo
- Publication number
- GB2110086A GB2110086A GB08232140A GB8232140A GB2110086A GB 2110086 A GB2110086 A GB 2110086A GB 08232140 A GB08232140 A GB 08232140A GB 8232140 A GB8232140 A GB 8232140A GB 2110086 A GB2110086 A GB 2110086A
- Authority
- GB
- United Kingdom
- Prior art keywords
- animal
- glass
- trace elements
- subcutaneous implant
- implant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007943 implant Substances 0.000 title claims abstract description 16
- 238000007920 subcutaneous administration Methods 0.000 title claims abstract description 12
- 239000011521 glass Substances 0.000 claims abstract description 34
- 241001465754 Metazoa Species 0.000 claims abstract description 22
- 239000011573 trace mineral Substances 0.000 claims abstract description 16
- 235000013619 trace mineral Nutrition 0.000 claims abstract description 16
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims abstract description 15
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229910052711 selenium Inorganic materials 0.000 claims abstract description 11
- 239000011669 selenium Substances 0.000 claims abstract description 11
- 239000011787 zinc oxide Substances 0.000 claims abstract description 7
- 239000000463 material Substances 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 claims 1
- JPJALAQPGMAKDF-UHFFFAOYSA-N selenium dioxide Chemical compound O=[Se]=O JPJALAQPGMAKDF-UHFFFAOYSA-N 0.000 abstract description 19
- 239000000203 mixture Substances 0.000 description 16
- 239000000470 constituent Substances 0.000 description 6
- 229910000272 alkali metal oxide Inorganic materials 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- 238000007496 glass forming Methods 0.000 description 3
- 239000000155 melt Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 150000004706 metal oxides Chemical class 0.000 description 3
- 239000000654 additive Substances 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 229910044991 metal oxide Inorganic materials 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 229910052755 nonmetal Inorganic materials 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- KKCBUQHMOMHUOY-UHFFFAOYSA-N Na2O Inorganic materials [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- -1 alkali metal oxides Chemical class 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000004031 devitrification Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 238000007499 fusion processing Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- UCUXYVNKFJJXDE-UHFFFAOYSA-N nitrate;hydrate Chemical compound O.[O-][N+]([O-])=O UCUXYVNKFJJXDE-UHFFFAOYSA-N 0.000 description 1
- 150000002843 nonmetals Chemical class 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- UOURRHZRLGCVDA-UHFFFAOYSA-D pentazinc;dicarbonate;hexahydroxide Chemical compound [OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Zn+2].[Zn+2].[Zn+2].[Zn+2].[Zn+2].[O-]C([O-])=O.[O-]C([O-])=O UOURRHZRLGCVDA-UHFFFAOYSA-D 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- CHWRSCGUEQEHOH-UHFFFAOYSA-N potassium oxide Chemical compound [O-2].[K+].[K+] CHWRSCGUEQEHOH-UHFFFAOYSA-N 0.000 description 1
- 229910001950 potassium oxide Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K13/00—Devices for grooming or caring of animals, e.g. curry-combs; Fetlock rings; Tail-holders; Devices for preventing crib-biting; Washing devices; Protection against weather conditions or insects
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K29/00—Other apparatus for animal husbandry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
- A61D7/00—Devices or methods for introducing solid, liquid, or gaseous remedies or other materials into or onto the bodies of animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/022—Artificial gland structures using bioreactors
-
- C—CHEMISTRY; METALLURGY
- C03—GLASS; MINERAL OR SLAG WOOL
- C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
- C03C3/00—Glass compositions
- C03C3/12—Silica-free oxide glass compositions
-
- C—CHEMISTRY; METALLURGY
- C03—GLASS; MINERAL OR SLAG WOOL
- C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
- C03C4/00—Compositions for glass with special properties
- C03C4/0035—Compositions for glass with special properties for soluble glass for controlled release of a compound incorporated in said glass
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Environmental Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Transplantation (AREA)
- Organic Chemistry (AREA)
- Materials Engineering (AREA)
- Geochemistry & Mineralogy (AREA)
- Biodiversity & Conservation Biology (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Wood Science & Technology (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Glass Compositions (AREA)
Abstract
A subcutaneous implant for supplying one or more trace elements to an animal is made from a zinc oxide based glass which is prepared in rod form, a short section of the rod being implanted under the skin of an animal. Typically the glass may contain selenium dioxide for supplying small quantities of selenium to the animal.
Description
SPECIFICATION
Glass implant
This invention relates to glass composition and in particular to water soluble glasses for the supply of trace elements to animals.
One of the problems involved in the husbandry of domesticated animals, e.g. cattle and sheep, is the provision of an adequate supply of trace elements. For example it has been found that, for the healthy growth of such animals, it is necessary that they ingest between 1 and 5 parts per million of selenium based on body weight. In some pastures such a level of selenium occurs naturally but in other areas, e.g. in areas of high rainfall, the natural selenium level is insufficient and must therefore be supplemented either in the form of medication or as an additive to the animal foodstuff. In practice however, because the required quantities of trace elements are so small, it is difficult to achieve the required dosage rate. Furthermore at levels above the required dose trace elements are in general dangerous poisons.
The object of the invention is to minimise or to overcome this disadvantage.
According to the invention there is provided a subcutaneous implant for an animal and adapted to supply one or more trace elements into the bloodstream of the animal, the implant comprising a body of a glass material at least the major proportion which includes one or more oxides of said one or more trace elements together with zince oxide.
A glass employed as a subcutaneous implant for an animal must be non-toxic, nonirritant and must dissolve at a suitable rate so as to supply an adequate level of one or more trace elements into the body fluids of an animal in which the glass is emplanted. We have found that glasses based on zince oxide, which acts as a glass modifying oxide, may be used for this purpose.
The term "glass modifying oxide" is understood to mean an oxide which, whilst it does not of itself form a glass, is capable of forming glass compositions in conjunction with others, generally oxide, glass forming materials. In the glass compositions described herein the trace element or elements may be present in the form of glass forming oxides or as additives together with one or more biologically inert or active glass forming oxides. The components of the glass composition are fused and thoroughly mixed and the melt is then cast e.g. into a rod. A portion of such a glass rod may then be inserted beneath the skin of an animal where the glass constituents slowly dissolve into the animals bloodstream.
In particular, glass compositions suitable for supplying controlled quantities of selenium e.g. to an animal, may be prepared from selenium dioxide (SeO2) and zinc oxide (ZnO) as the major constituents together with oxides of other metals or non metals as minor constituents. These latter minor constituents may be employed to determine the water solubility, and hence the selenium release rate of the glass composition. The technique of solubility adjustment is more fully described in our published specification No. 1,512,637 (C F
Drake 49). It has been found in general that the upper limit for the molecular percentage of selenium dioxide in such glass composition is 60 mol % above which the glass composition devitrifies. Also, at selenium concentrations below 40 mol % the glass is hygroscopic and thus unsuitable for controlled selenium release.Small quantities of metal oxides, e.g. alkali metal oxides, may be incorporated in the glass composition to adjust the softening point, ensure freedom from devitrification, and to control the rate of solution.
Thus, for example for glasses of the molar composition xM2O : (50-x) ZnO : 50 SeO2 where M2O is an alkali metal oxide or a mixture of alkali metal oxides, those glasses wherein X < 5 are affectively insoluble whilst those wherein X > 1 8 disintegrate rapidly in water. Therefore, to obtain a useful composition, x should lie within the range 5 to 18.
The glass is prepared by mixing the constituent oxides, i.e. zinc oxide, selenium oxide and optionally other metal and/or non metal oxides, in dry powder form. The mixture is fused into a homogeneous material at a temperature of 500 to 700 for 10 Min. to 1 hr.
in an air atmosphere. Conveniently the glass may be fused in a platinum crucible. The melt may then be cast and cooled. Advantageously the glass composition is formed as a small smooth body, e.g. by drawing into a rod which is then subdivided into short lengths, which may be implanted beneath the skin of an animal so as to release selenium directly into the animal's body fluids.
It will be clear to those skilled in the art that the carbonate, hydroxide nitrate etc. of one or more constituent metals may be used in place of the metal oxide as those components decompose to form the respective oxide during the fusion process.
The following examples illustrate the invention:
Example 1
0.67 g anhydrous sodium carbonate, 1.28 g potassium nitrate, 5.6 g selenium dioxide and 4.0 g basic zinc carbonate were fused for 15 Mins. in a platinum crucible at a temperature of 600 C and in an air atmosphere. The total weight loss on fusion was 2.38 g, this loss being attributed to the evolution of CO2,
NO2, 2, H20 and some SeO2. The final composition of the clear yellow glass was:
Na2O 6.59 mol % K20 6.61 mol % ZnO 36.61 mol % SeO2 50. 19 mol %
A 3 mm rod drawn from this melt was
immersed in new-born calf serum at a temperature of 38 C and was found to dissolve at a rate of 0.53 mg/day.
Example 2
A glass composition was prepared containing 50.6 mol % selenium dioxide; 38. mol % zinc oxide and 10.8 mol % potassium oxide (K20).
The glass was cast, allowed to cool and was then crushed. A weighed portion of the glass was immersed in new-born calf serum at a temperature of 38to. The dissolution rate of the glass under these conditions was found to be 25 ijg/cm2/hr.
Claims (4)
1. A subcutaneous implant for an animal and adapted to supply one or more trace elements into the bloodstream of the animal, the implant comprising a body of a glass material at least the major proportion of which includes one or oxides of said one or more trace elements together with zinc oxide
2. A subcutaneous implant as claimed in claim 1 and in which said one or more trace elements include selenium.
3. A subcutaneous implant as claimed in claim 1 or 2, and in the form of a rod.
4. A subcutaneous implant for an animal substantially as described herein with reference to the Examples.
4. An animal subcutaneous implant substantially as described herein with reference to the Examples.
CLAIMS (25th Jan 1983)
1. A subcutaneous implant for an animal and adatped to supply one or more trace elements into the bloodstream of the animal, the implant comprising a body of a water soluble glass material at leas the major porportin of which includes one or more oxides of said one or more trace elements together with zinc oxide.
2. A subcutaneous implant as claimed in claim 1 and in which said one or more trace elements include selenium.
3. A subcutaneous implant as claimed in claim 1 or 2, and in the form of a rod.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB08232140A GB2110086B (en) | 1978-09-26 | 1982-11-10 | Subcutaneous implant |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB7838222A GB2030559B (en) | 1978-09-26 | 1978-09-26 | Zinc oxide glass composition |
| GB08232140A GB2110086B (en) | 1978-09-26 | 1982-11-10 | Subcutaneous implant |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| GB2110086A true GB2110086A (en) | 1983-06-15 |
| GB2110086B GB2110086B (en) | 1983-10-12 |
Family
ID=26268978
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB08232140A Expired GB2110086B (en) | 1978-09-26 | 1982-11-10 | Subcutaneous implant |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB2110086B (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2123693A (en) * | 1982-07-20 | 1984-02-08 | Nat Res Dev | Sustained release device |
| EP0140538A3 (en) * | 1983-09-15 | 1986-10-08 | Stc Plc | Controlled release system |
| US4661339A (en) * | 1982-07-20 | 1987-04-28 | National Research Development Corp. | Sustained release composition |
| GB2178422B (en) * | 1985-08-02 | 1990-02-14 | Stc Plc | Prosthesis formed from water-soluble phosphate glass. |
-
1982
- 1982-11-10 GB GB08232140A patent/GB2110086B/en not_active Expired
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2123693A (en) * | 1982-07-20 | 1984-02-08 | Nat Res Dev | Sustained release device |
| US4661339A (en) * | 1982-07-20 | 1987-04-28 | National Research Development Corp. | Sustained release composition |
| EP0140538A3 (en) * | 1983-09-15 | 1986-10-08 | Stc Plc | Controlled release system |
| GB2178422B (en) * | 1985-08-02 | 1990-02-14 | Stc Plc | Prosthesis formed from water-soluble phosphate glass. |
Also Published As
| Publication number | Publication date |
|---|---|
| GB2110086B (en) | 1983-10-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4407786A (en) | Glass composition | |
| US4283227A (en) | ZnO--SeO2 --R2 O soluble glass | |
| KR900006413B1 (en) | Water Soluble Glassware | |
| US4350675A (en) | Controlled release glass | |
| US4678659A (en) | Therapeutic devices incorporating water soluble glass compositions | |
| US5223246A (en) | Effervescent composition, its production and use | |
| US4123248A (en) | Controlled release fertilizer | |
| GB2081703A (en) | Controlled Release Glass | |
| US20080208340A1 (en) | Synthetic bone graft | |
| EP0080835B1 (en) | Pellets for oral administration to ruminants | |
| GB2164557A (en) | Rumen bolus of soluble glass | |
| GB2110086A (en) | Subcutaneous implant | |
| GB2077585A (en) | Sustained-release bodies of soluble glass tubules | |
| Knott | Glasses: agricultural applications | |
| JP3021287B2 (en) | Antibacterial agent for sandbox | |
| GB2163346A (en) | Water soluble glass rumen boluses for administration to ruminant animals | |
| GB2124899A (en) | Improved rumen bolus | |
| US20030060404A1 (en) | Aqueous glycerol formulations of somatotropin | |
| AU2018101611A4 (en) | Ethephon Formulation | |
| EP0090368B1 (en) | Anthelmintic preparations | |
| JPS63307807A (en) | Disinfectants in cement making solutions | |
| WO1998029131A9 (en) | Aqueous glycerol formulations of somatotropin | |
| AU596629B2 (en) | Selenium formulations for pasture/soil application | |
| RU1783970C (en) | Method of keeping form animals | |
| CA2281288A1 (en) | Method for reducing deflagration of azinphos-methyl |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PCNP | Patent ceased through non-payment of renewal fee |